000 01514 a2200397 4500
005 20250516042547.0
264 0 _c20130124
008 201301s 0 0 eng d
022 _a1559-1166
024 7 _a10.1007/s12031-011-9570-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMelcangi, Roberto Cosimo
245 0 0 _aModifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease.
_h[electronic resource]
260 _bJournal of molecular neuroscience : MN
_cJan 2012
300 _a177-83 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCerebral Cortex
_xmetabolism
650 0 4 _aCorpus Striatum
_xmetabolism
650 0 4 _aDisease Models, Animal
650 0 4 _aMale
650 0 4 _aNerve Degeneration
_xmetabolism
650 0 4 _aOxidopamine
_xtoxicity
650 0 4 _aParkinsonian Disorders
_xchemically induced
650 0 4 _aRats
650 0 4 _aSteroids
_xmetabolism
650 0 4 _aSubstantia Nigra
_xmetabolism
650 0 4 _aSympatholytics
_xtoxicity
700 1 _aCaruso, Donatella
700 1 _aLevandis, Giovanna
700 1 _aAbbiati, Federico
700 1 _aArmentero, Marie-Therese
700 1 _aBlandini, Fabio
773 0 _tJournal of molecular neuroscience : MN
_gvol. 46
_gno. 1
_gp. 177-83
856 4 0 _uhttps://doi.org/10.1007/s12031-011-9570-y
_zAvailable from publisher's website
999 _c20926173
_d20926173